Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cpt.3101 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance.
Ther Adv Neurol Disord
December 2024
Department of Biomedical Sciences, Humanitas University, Milan, Italy.
In multiple sclerosis (MS), increasing disability is considered to occur due to persistent, chronic inflammation trapped within the central nervous system (CNS). This condition, known as smoldering neuroinflammation, is present across the clinical spectrum of MS and is currently understood to be relatively resistant to treatment with existing disease-modifying therapies. Chronic active white matter lesions represent a key component of smoldering neuroinflammation.
View Article and Find Full Text PDFEditorial: Photodynamic therapy: challenges and innovations for treating cancer.
Front Oncol
December 2024
Institute of Research and Development (IP&D), Universidade do Vale do Paraiba (UNIVAP), São José dos Campos, SP, Brazil.
Global research progress of nanomedicine and colorectal cancer: a bibliometrics and visualization analysis.
Front Oncol
December 2024
Proctology Department, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Background: Surgery and chemoradiotherapy are the main clinical treatment methods for colorectal cancer (CRC), but the prognosis is poor. The emergence of nanomedicine brings bright light to the treatment of CRC. However, there has not been a comprehensive and systematic analysis of CRC and nanomedicine by bibliometrics.
View Article and Find Full Text PDFConversion surgery for stage IV gastric cancer after third-line immunotherapy: a case report.
Front Oncol
December 2024
The 5-year overall survival rate for stage IV gastric cancer is lower than 10%, despite the development of systemic therapy. Conversion surgery has shown to improve survival outcomes in patients with durable clinical response on chemotherapy. We report a clinical case of a patient, who underwent conversion surgery after pembrolizumab in the third-line setting for stage IV gastric cancer.
View Article and Find Full Text PDFCost-effectiveness of camrelizumab plus rivoceranib for advanced hepatocellular carcinoma in the context of regional disparities in China.
Front Oncol
December 2024
Department of Oncology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Objective: To assess the cost-effectiveness of combining camrelizumab with rivoceranib versus sorafenib as initial treatment options for advanced hepatocellular carcinoma (HCC) across different developmental regions in China.
Methods: Utilizing TreeAge Pro and data from the phase III randomized CARES-310 clinical trial, a model based on Markov state transitions was developed. Health state utility values were derived from the CARES-310 trial, and direct medical costs were obtained from relevant literature and local pricing data.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!